In the evolving landscape of global healthcare, Jiangxi Serum Pharma Industries Co., Ltd. stands as a beacon of pharmaceutical integrity. Since our inception in 2017, we have bridged the gap between cutting-edge Chinese manufacturing and global healthcare needs. With an annual sales volume exceeding $10,000,000 USD, we aren't just a supplier; we are a strategic growth engine for over 500 long-term international partners.
Our flagship product, Amoxiclav (Amoxicillin and Potassium Clavulanate Tablets), represents the pinnacle of broad-spectrum antibiotic therapy. By combining the bactericidal power of Amoxicillin with the beta-lactamase inhibiting prowess of Potassium Clavulanate, we provide a definitive solution against resistant bacterial strains.
The formulation of Amoxicillin and Potassium Clavulanate is more than just a mixture; it is a bio-chemical synergy designed to overcome bacterial resistance. Amoxicillin, a semi-synthetic penicillin, targets cell wall synthesis. However, many bacteria produce beta-lactamase enzymes that neutralize it.
Our Co-Crystallization technology ensures that the volatile Potassium Clavulanate remains stable throughout the shelf life, preventing degradation in humid tropical climates.
Utilizing advanced bio-fermentation for raw material synthesis, ensuring high purity levels that exceed USP/BP standards for fewer side effects.
Serum Pharma offers customized Pre-Mix services, allowing for rapid production of varied dosage forms (375mg, 625mg, 1g) to meet specific market demands.
Most suppliers provide a standard product. Serum Pharma provides Information Gain through deep supply chain transparency. We monitor the raw material market (Penicillin G and Clavulanic Acid precursors) to provide our clients with predictive pricing and inventory security. This "Pre-emptive Supply Chain" model reduces lead times by 30% compared to industry averages.
China is the global powerhouse for Active Pharmaceutical Ingredients (APIs). As a premier Amoxiclav supplier, Jiangxi Serum Pharma leverages its strategic location to ensure:
In a post-pandemic world, supply chain "fragility" is the enemy. We provide Resilience through multi-source API procurement and 24/7 monitoring of regulatory shifts in China's pharmaceutical landscape.
Antibiotic needs vary wildly across the globe. Serum Pharma doesn't believe in a one-size-fits-all approach. We specialize in Localization Support to ensure compliance and clinical efficacy in diverse regions.
Focus on tropical stability packaging (Alu-Alu blister packs) to protect Potassium Clavulanate from high humidity and temperature excursions.
Comprehensive CTD/eCTD Dossier support and Bioequivalence (BE) studies to facilitate rapid local registration and MOH approvals.
Tiered pricing models and private labeling (OEM/ODM) services for major pharmacy chains and hospital networks looking for "Best-in-Class" house brands.
The future of Amoxiclav and Potassium Clavulanate Tablets lies in the intersection of biology and technology. At Serum Pharma, we are exploring:
Deep dive into the transition from shark-based to plant-based squalene in pharma...
Read More →Why this molecule remains a critical cornerstone in modern emergency medicine...
Read More →The FDA's approval of Lilly's oral GLP1 molecule and its impact on the global peptide supply chain. Serum Pharma is monitoring these oral delivery technologies for antibiotic applications.
Read More →
